CALL/AMGEN/500/0.1/20.09.24 | Market Closed - BOERSE MUENCHEN 02:26:06 2024-07-11 pm EDT | ||
| 0.021 EUR | 0.00% |
|
| Current month | -8.70% | ||
| 1 month | +50.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.021 | 0.00% |
| 24-07-10 | 0.021 | +5.00% |
| 24-07-09 | 0.02 | +11.11% |
| 24-07-08 | 0.018 | -14.29% |
| 24-07-05 | 0.021 | +75.00% |
Real-time BOERSE MUENCHEN
Last update July 11, 2024 at 02:26 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GG2YK9 |
| ISIN | DE000GG2YK96 |
| Date issued | 2024-01-30 |
| Strike | 500 $ |
| Maturity | 2024-09-20 (71 Days) |
| Parity | 10 : 1 |
| Emission price | 0.02 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.048 € |
|---|---|
| Lowest since issue | 0.007 € |
| Spread | 0.1 € |
| Spread % | 83.33% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
325.1
USD
Average target price
316.1
USD
Spread / Average Target
-2.75%
- Stock Market
- Warrants
- Warrant
